These findings suggest that unveiling the mechanisms that connect NRF2 to HIPK2/p53 pathway could be worthwhile in order to predict cancer cell response to anticancer therapies, since all three molecules are important for therapy response in cancer [3,11,45]. This evidence concerns the gene NFE2L2 and cancer.